Skip to main content
OpenTrials
Completed

NCT Number: NCT02625129

Effectiveness of and Satisfaction With a Pharmacist-managed Travel Medicine Clinic

This study will evaluate the clinical effectiveness of, and patient satisfaction with, pre-travel consultations provided by a pharmacist with specialty training in travel medicine and the authorization to prescribe medications and administer vaccinations.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Travel Medicine

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Travel Health Network

St. Albert, Alberta, T8N5H9, Canada

About this study

The study will be conducted at the Travel Health Network, a full-service travel medicine clinic located in St. Albert, Alberta. Care will be provided by a pharmacist with a specialized practice in travel medicine, authorization to prescribe vaccines and prescription drugs, and authorization to administer vaccines by injection.

The study will be a prospective mixed-methods cohort study, describing patients receiving care from a pharmacist-managed travel medicine clinic and their travel health needs, and evaluating their adherence to recommended vaccines and oral therapies, satisfaction with the care provided, and their health status and management of health issues arising while travelling. Chart reviews will elicit descriptive quantitative data related to patients' travel medicine needs and adherence to recommended vaccinations and oral pharmacotherapy, followed by surveys containing open-ended qualitative questions to elicit overall patient satisfaction and the management of any health issues encountered during travel. Due to the nature of the study involving patients presenting to the clinic for a consultation, neither a control group nor blinding is possible.

A convenience sample of 100 subjects will be enrolled.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Receiving a pre-travel consultation at the Travel Health Network clinic in St. Albert, Alberta, Canada

Exclusion criteria

  • Travellers with an expected return date after September 1, 2016
  • Those receiving consultations as part of a group with the same itinerary (e.g., families, group vacations) will be asked to identify one member to participate in order to minimize repetition among participants.

Treatment and study plan

Pharmacist-provided travel care

Other

Subjects will receive a pre-travel consultation from a pharmacist with specialty training in travel medicine, and with authorization to prescribe medications and vaccines and administer injections

Primary outcomes

  1. The proportion of recommended pre-travel vaccinations administered before departure according to chart review

    Time frame: Up to 7 months.

    From date of pre-travel consultation until the date of travel departure according to participant's planned itinerary, assessed up to September 2016.

  2. The proportion of recommended pre-travel oral pharmacotherapies dispensed before departure by a community pharmacy according to electronic health record

    Time frame: Up to 7 months.

    From date of pre-travel consultation until the date of travel departure according to participant's planned itinerary, assessed up to September 2016.

Secondary outcomes

  1. Average satisfaction (along 1-5 scale) with care provided elicited through an online survey post-travel

    Time frame: 1 week following return from travel according to participant's planned itinerary

  2. Frequency of reason(s) for declining any recommended vaccines or medications according to participant self-report through an online survey

    Time frame: 1 week following return from travel according to participant's planned itinerary

    Response options: didn't feel I was at risk, cost, concern about vaccine ingredients or safety, other (specify)

  3. Number of reports of any health issues over the course of travel according to participant self-report through an online survey

    Time frame: 1 week following return from travel according to participant's planned itinerary

    Response options: Traveller's diarrhea, Altitude sickness, Malaria, Fever (Dengue, Chikungunya), Respiratory illness, Other (specify)

  4. Frequency of management strategies of any health issues over the course of travel according to participant self-report through an online survey

    Time frame: 1 week following return from travel according to participant's planned itinerary

    Response options: Nothing - it went away on its own, Took a non-prescription medication I had purchased before departure, Took a non-prescription medication I purchased while travelling, Called or emailed the Travel Health Network for advice, Searched the internet for guidance on how to manage it, Saw a physician while travelling, Saw a physician upon returning home, Other (specify)

Sponsors and collaborators

Lead sponsor

University of Waterloo

Other

Collaborators

  • Travel Health Network
  • University of Mississippi Medical Center

Registry information

Official study title

Determining the Clinical Effectiveness and Patient Satisfaction of a Pharmacist-managed Travel Medicine Clinic Under an Expanded Scope of Practice

Important dates

Study start
2016
Primary completion
2017
Study completion
2017
First posted
Dec 9, 2015
Registry last updated
Jan 19, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.